RT Journal Article
SR Electronic
T1 ▾ Nabumetone (Relifex) - another NSAID
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 41
OP 43
DO 10.1136/dtb.26.11.41
VO 26
IS 11
YR 1988
UL http://dtb.bmj.com/content/26/11/41.abstract
AB Last year nabumetone (Relifex - Bencard) was introduced for the treatment of rheumatoid arthritis (RA) and osteoarthritis (OA). It is a non-steroidal anti-inflammatory drug (NSAID) which, like several other NSAIDs, is claimed to have the advantage over other NSAIDs of a lower risk of gastric mucosal irritation. Does the clinical evidence support this claim?